Daily
250 words
6/10
Rating

14 August 2026

India's pharmaceutical exports

Pharmaceutical exports are a critical component of India's trade balance and industrial policy, serving as a key indicator for the 'Pharmacy of the World' status and economic growth analysis in GS3.

1 min read 2 questions 2 prelims

Notes

  • India's pharmaceutical exports reached $8.1 billion in Q1 (ended June), a 6.8% YoY increase.
  • Drug formulations and biologicals constitute the largest export segment at $5.98 billion (73.85% of total).
  • Bulk drugs and intermediates grew by 13.84% to $1.36 billion; vaccine exports grew by 35.68% to $0.39 billion.
  • NAFTA remains the largest regional market, accounting for 34.28% of total exports.
  • The U.S. is the single largest export destination, accounting for 30.89% ($2.50 billion) of total exports.
  • Top five export destinations: U.S., Brazil, U.K., Netherlands, and France.
  • Nearly 75% of exports are directed to NAFTA, Europe, Africa, Latin America, and the Caribbean.
  • The top 25 export destinations account for approximately 70% of total pharmaceutical shipments.
  • Total pharmaceutical exports for FY26 were $31.11 billion, reflecting a 2% YoY growth.

Questions

  1. Analyze the factors contributing to India's sustained growth in pharmaceutical exports and discuss the significance of market diversification for the sector's long-term stability. 150 words
    Attempt this — 150 words in 8 min
    0 / 150 words 8:00
  2. India's position as the 'pharmacy of the world' is increasingly defined by its ability to balance manufacturing scale with regulatory credibility. Discuss how India can leverage its pharmaceutical export growth to strengthen its position in global healthcare supply chains. 250 words
    Attempt this — 250 words in 11 min
    0 / 250 words 11:00

Prelims

  1. Which of the following regions accounts for the largest share of India's pharmaceutical exports?

  2. What was the largest category of pharmaceutical exports from India in the first quarter ended June?